Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma
- 1 April 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9161) , 1326
- https://doi.org/10.1016/s0140-6736(99)00403-1
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Anterior Ischemic Optic Neuropathy Secondary to Interferon AlfaArchives of Ophthalmology (1950), 1995
- Interferon-Associated RetinopathyArchives of Ophthalmology (1950), 1993